Compounds > 5,8,11,14-eicosatetraynoic acid
Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Delayed Effects, Prenatal Exposure

5,8,11,14-eicosatetraynoic acid has been researched along with Delayed Effects, Prenatal Exposure in 1 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yu, WK1
Wells, PG1

Other Studies

1 other study available for 5,8,11,14-eicosatetraynoic acid and Delayed Effects, Prenatal Exposure

ArticleYear
Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to a teratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase, and in vivo studies using pregnant CD-1 mice.
    Toxicology and applied pharmacology, 1995, Volume: 131, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Abnormalities, Drug-Induced; Animals; Biotransformation; Catalysis;

1995